Long-read epigenomic diagnosis and prognosis of Acute Myeloid Leukemia
Author Information
Author(s): Lamba Jatinder, Marchi Francisco, Landwehr Marieke, Schade Ann-Kathrin, Shastri Vivek, Ghavami Matin, Sckaff Fernando, Marrero Richard, Nguyen Nam, Mansinghka Vikash, Cao Xueyuan, Slayton William, Starostik Petr, Ribeiro Raul, Rubnitz Jeffrey, Klco Jeffery, Gamis Alan, Triche Timothy, Ries Rhonda, Kolb Edwards Anders, Aplenc Richard, Alonzo Todd, Pounds Stanley, Meshinchi Soheil, Cogle Christopher, Elsayed Abdelrahman
Hypothesis
Can DNA methylation data improve the diagnosis and prognosis of Acute Myeloid Leukemia?
Conclusion
The study developed a new method for diagnosing and predicting outcomes in Acute Myeloid Leukemia using DNA methylation data.
Supporting Evidence
- The study predicted 27 acute leukemia subtypes with 96.3% accuracy in discovery cohorts.
- A prognostic classifier for overall survival was developed with a hazard ratio of 4.40.
- A targeted 38CpG AML signature was predictive of overall survival with a hazard ratio of 3.84.
- The study utilized long-read sequencing for simultaneous whole-genome and epigenome sequencing.
Takeaway
This study found a way to better understand and predict how patients with a type of blood cancer called Acute Myeloid Leukemia will do by looking at their DNA.
Methodology
The study harmonized DNA methylation data from multiple cohorts and developed classifiers for diagnosis and prognosis.
Statistical Information
P-Value
P<0.0001
Confidence Interval
95% CI=3.45–5.61
Statistical Significance
p<0.0001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website